Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Pactiv Evergreen $6.7 billion acquisition by Novolex
We are advising Packaging Finance as the majority shareholder of Pactiv Evergreen in connection with the acquisition
Citi acquisition of Barclays American Airlines co-branded card portfolio
We are advising Citi on the acquisition
Avon Products bankruptcy court approval of Natura settlement and $125 million sale
We are advising Natura on its settlement with the Avon debtors and purchase of the Avon International business
Ark & Partners tender offer for Soomgo
We advised Ark & Partners on the transaction
Gersh acquisition of You First
We advised Gersh on the acquisition and the related financing
Cross Country Healthcare $615 million acquisition by Aya Healthcare
We are advising Cross Country Healthcare on the transaction
State Street Global Advisors on the Bain Capital led acquisition of Envestnet
We advised State Street Global Advisors as a strategic partner in connection with the acquisition
Campbell Soup sale of Noosa Yoghurt to Lakeview Farms
We are advising Campbell Soup on the sale
Summit Materials $11.5 billion acquisition by Quikrete Holdings
We are advising Summit Materials on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction